Pulmonary Arterial Hypertension (PAH) Panel, Sequencing and Deletion/Duplication
Preferred test to confirm diagnosis of pulmonary arterial hypertension (PAH), especially in those with a family history of PAH.
Massively Parallel Sequencing/Exonic Oligonucleotide-based CGH Microarray
Lavender (EDTA) or yellow (ACD Solution A or B).
Transport 3 mL whole blood. (Min: 1 mL)
Submit the Patient History Form for Pulmonary Arterial Hypertension with the Electronic Packing List.
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable
Refer to report.
Compliance Statement C: For human genetic inheritable conditions and mutations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
Genes tested: ACVRL1, BMPR2, CAV1, EIF2AK4, ENG, KCNA5**, KCNK3, SMAD9
** Deletion/duplication detection is not available for this gene.
81405; 81406; 81479
|Component Test Code*||Component Chart Name||LOINC|
|2009346||PAH Pan. Seq/DelDup, Specimen||31208-2|
|2009349||PAH Pan. Seq/DelDup, Interp||49014-4|
- Pulmonary Arterial Hypertension